Second-Line Chemotherapy for Prostate Cancer: Patient Characteristics and Survival

First-line chemotherapy with docetaxel in patients with progressive castrate metastatic prostate cancer has been shown to improve overall survival compared with mitoxantrone-based therapies. The use and outcomes of chemotherapy after first-line antimicrotubule-based therapy have not been well descri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical prostate cancer 2005-09, Vol.4 (2), p.86-90
Hauptverfasser:	Beekman, Kathleen W., Fleming, Mark T., Scher, Howard I., Slovin, Susan F., Ishill, Nicole M., Heller, Glenn, Kelly, W. Kevin
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - pathology Alkaline phosphates Antineoplastic Combined Chemotherapy Protocols - therapeutic use Clinical trials Humans Male Metastatic disease Microtubules - drug effects Prostatic Neoplasms - drug therapy Prostatic Neoplasms - mortality Prostatic Neoplasms - pathology Retreatment Ribonucleoprotein, U4-U6 Small Nuclear Saccharomyces cerevisiae Proteins Taxanes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!